Cadila Healthcare reports 17% fall in Q2 consolidated net profit

05 Nov 2018 Evaluate

Cadila Healthcare has reported results for second quarter ended September 30, 2018.

The company has reported a rise of 48.18% in its net profit at Rs 666.50 crore for the quarter under review as compared to Rs 449.80 crore for the same quarter in the previous year. Total income of the company increased by 13.77% at Rs 2,054.30 crore for Q2FY19 as compared Rs 1,805.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 17.05% in its net profit at Rs 417.50 crore for the quarter under review as compared to Rs 503.30 crore for the same quarter in the previous year. Total income of the company decreased by 7.79% at Rs 2,991.60 crore for Q2FY19 as compared Rs 3,244.40 crore for the corresponding quarter previous year.

Zydus Lifesciences Share Price

890.50 -2.95 (-0.33%)
28-Jan-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1632.35
Dr. Reddys Lab 1233.60
Cipla 1314.10
Zydus Lifesciences 890.50
Lupin 2142.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×